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Abstract. A total of 1,885 blood and stool samples of four main protozoan parasitic infections were retrospectively
reviewed from January, 2000 to April, 2004. Eleven of the 1,350 stool samples were shown positive for
Cryptosporidium and Giardia infections; one of the 5 cases was clinically diagnosed as gastrointestinal
cryptosporidiosis, while 6 cases were giardiasis. In patients with giardiasis, children were among the high-risk
groups, making up 66.7% of these patients. The common presenting signs and symptoms were: diarrhea (83.3%),
loss of appetite (83.3%), lethargy (83.3%), fever (66.7%), nausea/vomiting (50.0%), abdominal pain (16.7%),
dehydration (16.7%) and rigor and chills (16.7%). Metronidazole was the drug of choice and was given to all
symptomatic patients (83.3%). For the blood samples, 28 of the 92 peripheral smears for Plasmodium spp infection
were diagnosed as malaria. The age range was from 4 to 57, with a median of 32.5 years. The sex ratio (M:F) was
3.6:1, while the age group of 30-44 years was the most commonly affected in both sexes. The majority of
patients were foreigners (60.7%) and non-professional (39%). Plasmodium vivax (71%) infection was the most
common pathogen found in these patients, along with a history of traveling to an endemic area of malaria (31%).
The predominant presenting signs and symptoms were: fever (27%), rigor and chills (24%), nausea/vomiting
(15%) and headache (8%). Chloroquine and primaquine was the most common anti-malarial regimen used (78.6%)
in these patients. The seroprevalence of toxoplasmosis in different groups was 258/443 (58%): seropositive for
IgG 143 (32.3%); IgM 67 (15%); and IgG + IgM 48 (10.8%). The age range was from 1 to 85, with a mean of 34
(± SD 16.6) years. The predominant age group was 21 to 40 years (126; 28.4%). The sex ratio (M:F) was 1.2:1.
Subjects were predominantly male (142; 32%) and the Malay (117; 26.4%). Of these, 32 cases were clinically
diagnosed with ocular toxoplasmosis. The range of age was from 10 to 56 years with a mean of 30.5 (± SD
12.05) years. The sex ratio (M:F) was 1:1.7. The majority were in the age group of 21 to 40 years, female (20;
62.5%), and Malay (17; 53%). They were also single (16; 50%), unemployed (12; 37%), and resided outside
Kuala Lumpur (21; 65.6%). The more common clinical presentations were blurring of vision (25; 78%), floaters
(10; 31%) and pain in the eye (7; 22%). We found that funduscopic examination (100%) and seropositivity for
anti-Toxoplasma antibodies (93.7%) were the main reasons for investigation. Choroidoretinitis was the most
common clinical diagnosis (69%), while clindamycin was the most frequently used antimicrobial in all cases.
Among HIV-infected patients, 10 cases were diagnosed as AIDS-related toxoplasmic encephalitis (TE) (9 were
active and 1 had relapse TE). In addition, 1 case was confirmed as congenital toxoplasmosis.
deaths each year (Suyaphun et al, 2002). Given this
information, we conducted this study to determine the
prevalence of four common protozoan parasitic
infections: Cryptosporidium parvum, Giardia lambia,
Plasmodium spp and Toxoplasma gondii. We also
aimed to determine the incidence of clinically evident
cases of these diseases in the UMMC, Kuala Lumpur.
These data will help to update our knowledge and
implement standard strategies in terms of prevention
and proper management of these diseases.
MATERIALS AND METHODS
Patients
This retrospective and descriptive study was
carried out in the University of Malaya Medical Center
(UMMC), Kuala Lumpur, a 863-bed facility and the
oldest university tertiary referral hospital in Malaysia.
Correspondence: Dr Veeranoot Nissapatorn,
Department of Parasitology, University of Malaya
Medical Center, 50603 Kuala Lumpur, Malaysia.
Tel: 603-7967 6618
E-mail: nissapat@hotmail.com
INTRODUCTION
Infectious diseases, once expected to be eliminated
as public health problems, remain the leading cause of
death worldwide (Marshall et al, 1997). To our
knowledge, parasitic infections remain highly
prevalent in the global arena, particularly in developing
countries. Among tropical diseases, malaria has been
identified as one of the most important public health
problems (Moe Lwin and Umenai, 1999) and is the
most important human parasitic disease, affecting over
200 million people and causing more than one million
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UMMC mainly serves as a public hospital and teaching
Center. A total of 1,885 records from January, 2000 to
April, 2004 in the Department of Parasitology were
reviewed for the 4 main protozoan infections. There
were 297 (15.8%) cases found to be positive by samples
(blood, serum and stool): 5 cases of gastrointestinal
cryptosporidiosis, 6 cases of giardiasis, 28 cases of
malaria and 258 (of 443) individuals seropositive for
anti-Toxoplasma (IgM, IgG or both) antibodies. All
positive cases were further investigated from the
medical record office, University of Malaya Medical
Center, based on the patients’ demographic profiles,
clinical presentations, relevant laboratory data and
treatment outcome. The patients’ information was
enlisted in the standard data collection sheet.
Diagnosis of diseases
Various investigations were carefully reviewed
according to our study’s objective and the following
standard criteria:
1. Diagnosis of giardiasis was made by stool
examination (concentration technique) for the
presence of Giardia cysts or trophozoites.
2. Diagnosis of cryptosporidiosis was made by
stool examination for the presence of
Cryptosporidium oocysts and confirmed by
modified Ziehl-Neelsen staining techniques.
3. Diagnosis of malaria was made by microscopic
identification (either thick or thin peripheral
blood smear) of the parasites in peripheral
blood smears.
4. Diagnosis of seropositivity for Toxoplasma
infection was via detection of anti-Toxoplasma
IgG, IgM or both by either one of the standard
ELISA commercial kits (Trinity Biotech, Bray,
Ireland, and Veda-lab, Alencon Cedex, France)
in accordance with the manufacturer’s
instructions. Positive results of these 4 parasitic
infections were identified and confirmed by
experienced technicians.
5. Clinical toxoplasmosis was detected in
different groups of patients and the diagnoses
were made as follows: (1) Ocular toxo-
plasmosis was diagnosed by presenting signs
and symptoms, ophthalmoscopic examination,
serologic evidence of Toxoplasma infection
and response to anti-Toxoplasma therapy. (2)
Congenital toxoplasmosis was diagnosed by
clinical signs and symptoms, relevant
investigations such as ultrasonography, CT
scan findings and serologic evidence of
Toxoplasma infection. (3) Toxoplasmic
encephalitis (TE) was empirically diagnosed
by HIV-positive status, CD4 <200 cells/mm3,
neurological signs and symptoms, serologic
evidence of anti-Toxoplasma antibodies and
response to anti-Toxoplasma therapy.
Statistical analysis
All findings were entered, edited and analyzed
using statistical software SPSS version 10 (SPSS Inc,
Chicago, Ill, USA).  Data with quantitative variables
were expressed as median and range, whereas
qualitative variables were expressed as frequency and
percentage.
RESULTS
Total of 5 cases were positive for Cryptosporidium
infection; however, only 1 case was symptomatic for
gastrointestinal cryptosporidiosis.  A one-year old child
presented with fever, diarrhea, and vomiting for 2 days
prior to admission. Her condition was diagnosed as
acute gastroenteritis, then stool examination confirmed
the presence of Cryptosporidium cysts. However, she
recovered with supportive treatment.  In six patients
with clinical evidence of giardiasis, children (67%) less
than 6 years-old were among the high-risk groups. Five
out of 6 patients (83.3%) were male. Diarrhea, loss of
appetite and lethargy were the most common
presentations. Metronidazole was the drug of choice
for treatment of giardiasis.  In this study, there was a
case of a 2-year-old patient whose parents were found
to harbor Giardia cysts when a routine laboratory
investigation was performed; however, he was
asymptomatic. No recurrence or deaths were noted
during the time of this study.
The demographic and clinical characteristics of 28
patients with malaria are listed in Table 1. The most
common species for malaria was Plasmodium vivax
(71%), followed by Plasmodium falciparum (14%),
Plasmodium malariae (4%) and mixed infections
between Plasmodium falciparum and Plasmodium
malariae (11%). There were no cases of malaria caused
by Plasmodium ovale found in this study. The age range
was from 4 to 57 years with a median of 32.5 years.
The ratio between male to female was 3.6:1 and the
preponderant age group was 21 to 40 years. The
majority of them were foreign patients (17; 60.7%)
from Australia, Bangladesh, India, Indonesia,
Myanmar, Pakistan, Sudan and Thailand. The
distribution among Malaysian patients (11; 39.3%)
was: Indian (6; 21%), Chinese (4; 14%), and Malay
(1; 4%). In addition, we found that 13 (46%) of these
patients were laborers and 14 (50%) of them had
history of traveling to endemic area of malaria. The
three common presenting signs and symptoms were:
fever (96.4%), chills and rigor (85.7%) and nausea with
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Table 1
Demographic characteristics and clinical relevant of
28 patients with malaria.
Characteristics Number of
patients (%)
The age range = 4 to 57 years
Median = 32.5 years
The sex ratio (M:F) = 3.6:1
Age group
≤ 20 2 (7)
21-40 16 (57)
41-60 10 (35.7)
Sex
Male 22 (78.6)
Female 6 (21.4)
Races
Malay 1 (3.6)
Chinese 4 (14.3)
Indian 6 (21.4)
Foreigner 17 (60.7)
Marital status
Single 7 (25)
Married 19 (68)
Not recorded 2 (7)
Occupation
Laborer 13 (46.4)
Nonlaborer 0
Unemployed 8 (28.6)
Not recorded 7 (25)
Address
Kuala Lumpur 10 (35.7)
Outsider 18 (64.3)
Risk factors
History of traveling to endemic area 14 (50)
Migration 6 (21.4)
History of blood transfusion 2 (7.2)
History of previous malaria 1 (3.6)
Clinical signs and symptoms
Fever 27 (96.4)
Chill and rigor 24 (85.7)
Nausea/vomitting 15 (53.6)
Headache 8 (28.6)
Organomegaly 7 (25)
Diarrhea 6 (21.4)
Sweating 5 (17.9)
Loss of weight and/or appetite 4 (14.3)
Joint pain 4 (14.3)
Abdominal pain 3 (10.7)
Myalgia 2 (7.1)
Investigation
Peripheral blood smear 28 (100)
Continued
Characteristics Number of
patients (%)
Hemoglobin count
(range = 10 to 172; mean 95.5 ± 46.7)
Normal value 6 (21.4)
Anemic condition
(mild, moderate and severe) 22 (78.6)
White blood cell count
(range = 1.03 to 12.4; mean = 5.9 ± 2.5)
Normal value 20 (71.4)
Below or above normal value 8 (28.6)
Red blood cell count
(range = 1.94 to 5.85; mean = 4.1 ± 0.89)
Normal 8 (28.6)
Below normal value 20 (71.4)
Diagnosis
Vivax malaria 20 (71.4)
Falciparum malaria 4 (14.3)
Malariae malaria 1 (3.6)
Mixed infection
(P. faiciparum and P. malariae) 3 (10.7)
Treatment
Chloroquine + primaquine 22 (78.6)
Chloroquine + doxycycline 5 (17.9)
Fansidar + quinine 1 (3.6)
vomiting (53.6%). We further found that a peripheral
blood smear was the most useful tool in routine
investigation; moreover, most patients had anemia with
their malarial infection. From this study, chloroquine
(3 days) and subsequently primaquine (14 days) was
the most common anti-malarial regimen used in
treating vivax malaria. For falciparum malaria,
chloroquine and doxycycline was the most commonly
used combination. There were no reports of anti-
malarial drug resistance or deaths in these patient cases.
Overall, the seroprevalence of toxoplasmosis in
different groups was 258/443 (58%): IgG (143; 32.3%),
IgM (67; 15%), and IgG+IgM (48; 10.8%). The age
range was from 1 to 85 with a mean of 34 (± SD) 16.6
years. The sex ratio (M:F) was 1.2:1. The predominant
age group was 21-40 years and male (202; 45.6% vs
241; 54.4%) particularly in HIV-positive patients (108;
66.7% vs 107; 66%) and in others (47; 38.8% vs 68;
56.2%). Chinese was the major ethnicity found (195;
44%) and most patients were HIV-positive (114;
70.3%); Malay were the dominant ones in ocular
disease (85; 52.8%), and other (55; 45.5%) groups as
shown in Table 2. Among seropositive (IgG, IgM or
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Table 2
Demographic characteristics of 443 individuals who came to this hospital during January 2000 to April 2004.
Characteristics Number of patients
HIV-patients Ocular patients Othersa Total
(162) (161) (121) (443)
The range of age = 1 to 85 years
Mean = 34  (± SD) 16.6 years
The sex ratio (M:F) = 1.2 : 1
Age Group
≤ 20 4 (2.5) 33 (20.5) 41 (34) 77 (17.4)
21-40 108 (66.7) 57 (35.4) 47 (38.8) 212 (48)
≥ 41 47 (29) 69 (43) 25 (20.7) 141 (31.8)
No information 3 (2) 2 (1.2) 8 (6.6) 13 (3)
Sex
Male 107 (66) 66 (41) 68 (56.2) 241 (54.4)
Female 55 (34) 95 (59) 53 (43.8) 202 (45.6)
Race
Malay 29 (18) 85 (52.8) 55 (45.5) 168 (38)
Chinese 114 (70.3) 37 (23) 44 (36.4) 195 (44)
Indian 12 (7.4) 37 (23) 20 (16.5) 69 (15.6)
Foreigner 7 (4.3) 2 (1.2) 2 (1.7) 11 (2.5)
Seroprevalence of toxoplasmosis
Nob 69 (42.6) 54 (33.5) 63 (52) 185 (41.8)
Yes: IgG 58 (35.8) 50 (31.1) 35 (29) 143 (32.3)
IgM 24 (14.8) 31 (19.3) 12 (10) 67 (15.1)
IgG+IgM 11 (6.8) 26 (16.1) 11 (9.1) 48 (10.8)
Total Ig 93 (57.4) 107 (66.5) 58 (48) 258 (58.2)
aOthers mean individual with pregnancy, congenital, generalized lymphadenopathy, or any immunosuppressed conditions.
The significant association were found between age group with HIV, ocular patients and others (p<0.05); sex with HIV and ocular
patients (p<0.05); and race with HIV, and ocular patients (p<0.05).
bThere were 2 cases who had no evidence of Toxoplasma status but clinically proven of  ocular toxoplasmosis.
both) individuals, we found that the main age group
was 21-40 years (126; 28.4%), male (142; 32%), and
Malay (117; 26.4%) (the data were not shown).
In 162 HIV-positive patients, 10 cases were
diagnosed as AIDS-related toxoplasmic encephalitis
– one patient had a previous history of toxoplasmic
encephalitis and later developed relapsing TE, while
the other 9 patients had active toxoplasmic encephalitis.
Tables 3 and 4 show the demographic and clinical
profiles of 32 cases of ocular toxoplasmosis from this
study. The range of age was from 10 to 56 years with a
mean of 30.5 (± SD) 12.05 years. The sex ratio (M:F)
was 1:1.7. The majority of them were in the age group
of 21 to 40 years. They were comprised of males (12;
37.5%) and females (20; 62.5%). The various ethnic
groups were: Malay (17; 53%), Chinese (8; 25%),
Indian (5; 15.6%), and foreigners (2; 6%). The majority
of them were single (16; 50%), unemployed (12; 37.%),
and outsiders (21; 65.6%). The common clinical
presentations were: blurring of vision (25; 78%),
photophobia (3; 9.4%), floaters (10; 31%), eye redness
(2; 6.3%), pain in the eye (7; 22%) and headache (4;
12.5%). The majority of these patients had involvement
of the right eye (17; 53%). Funduscopic examination
(100%) and seropositivity for anti-Toxoplasma (IgG,
IgM or both) antibodies (93.7%) were the main
investigations found in this study. Choroidoretinitis
was the most common clinical diagnosis (22; 68.8%).
Clindamycin was the most frequent drug used both in
single or combined forms (56.3%) in most cases.
Only 1 case of congenital toxoplasmosis was
reported during the time of our study as shown in Table
5.
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Table 3
Demographic profiles of 32 cases of ocular
toxoplasmosis.
Demographic Number of
characteristics patients (%)
The range of age = 10 to 56 years
Mean = 30.5 ± 12.05 years
The sex ratio (M:F) = 1 : 1.7
Age Group
≤ 10 1 (3.1)
11-20 7 (22)
21-30 9 (28.1)
31-40 8 (25)
41-50 5 (15.6)
≥ 51 2 (6.3)
Sex
Male 12 (37.5)
Female 20 (62.5)
Race
Malay 17 (53.1)
Chinese 8 (25.0)
Indian 5 (15.6)
Foreigner 2 (6.3)
Marital status
Single 16 (50.0)
Married 11 (34.4)
No information 5 (15.6)
Occupation
Laborer 3 (9.4)
Non-laborer 6 (18.8)
Unemployed 12 (37.5)
Not recorded 11 (34.4)
Address
Kuala Lumpur 5 (15.6)
Outsider 21 (65.6)
Not recorded 6 (18.8)
Table 4
Clinical manifestation, investigation and treatment
outcome of these patients.
Table 4 (continued)
Characteristics Number of
patient (%)
Floaters
No 18 (56.3)
Yes 10 (31.3)
Not recorded 4 (12.5)
Redness of eye
No 26 (81.3)
Yes 2 (6.3)
Not recorded 4 (12.5)
Pain in the eye
No 21 (65.6)
Yes 7 (21.9)
Not recorded 4 (12.5)
Fever
No 28 (87.5)
Yes 0
Not recorded 4 (12.5)
Headache
No 24 (75.0)
Yes 4 (12.5)
Not recorded 4 (12.5)
Affected eye(s)
Left 9 (28.1)
Right 17 (53.1)
Bilateral 3 (9.4)
Not recorded 3 (9.4)
Investigation
Funduscopy examination 32 (100)
Serology
IgM 4 (12.5)
IgG 18 (56.3)
Both 8 (25.0)
Not recorded 2 (6.3)
Diagnosis
Retinochoroiditis
No 10 (31.2)
Yes 22 (68.8)
Uveitis
No 22 (68.8)
Anterior uveitis 3 (9.4)
Posterior uveitis 1 (3.1)
Panuveitis 6 (18.8)
Treatment
Clindamycin 6 (18.8)
Prednisolone 1 (3.1)
Azithromycin 3 (9.4)
Fansidar 1 (3.1)
Combination 12 (37.5)
(clindamycin +prednisolone,
fansidar, and azithromycin)
Prednisolone + azithromycin 6 (18.8)
Not recorded 3 (9.4)
Characteristics Number of
patient (%)
Signs and symptoms
Blurring of vision
No 3 (9.4)
Yes 25 (78.1)
Not recorded 4 (12.5)
Photophobia
No 25 (78.1)
Yes 3 (9.4)
Not recorded 4 (12.5)
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DISCUSSION
Seven cases of symptomatic gastrointestinal
protozoan infections mostly occurred in children. This
indicates that parasitic infections are still encountered in
our setting, even though in small numbers. The prevalence
of these two organisms varied according to geographical
distribution (Cross et al, 1985; Kamel et al, 1994;
Gambhir et al, 2003). In a case of cryptosporidiosis, no
specific treatment was given to the patient; however, her
condition spontaneously improved. This could be due to
the fact that Cryptosporidium is an acute, self-limiting
gastro-enteritis in immunocompetent patients, whereas
it is a chronic and possibly life-threatening illness in
immunocompromized patients. Moreover, after a
literature review, we found no drug to date that has proven
to be effective in killing this parasite (Casemore et al,
1985; Kadappu et al, 2002).  Cases of giardiasis can be
successfully treated with metronidazole in affected
patients. However, a few current studies reported that
albendazole alone or in combination with praziquantel
could be a promising agent in treating this protozoan
parasite and co-existing organisms (Penggabean et al,
1998; Pengsaa et al, 2002).  Outbreaks of food-waterborne
giardiasis and/or cryptosporidiosis in day care centers and
travelers returning from the tropics have been reported
(Combee et al, 1986; de Lalla et al, 1992; Lee et al, 2002);
however, no such outbreaks have occurred in the
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Table 5
A report of clinically evident case of congenital toxoplasmosis.
Characteristics Patient
Age 3 years old
Gender Male
Ethnic Malay
Nationality Malaysian
Antenatal history His mother was 41 years old with G5P4 and all normal children before
his birth. During her 6 months pregnancy, she had fever for 1week
with exposed to chicken pox
Ultrasound examination Ventriculomegaly appeared on the fetal brain
Postnatal history He was a term baby with normal delivery in November 2001
In 2001: Clinical manifestation Hydrocephalus
Investigation
Serodiagnosis Positive for IgM anti-Toxoplasma antibody in the mother
Positive for IgM and IgG anti-Toxoplasma antibodies in
the new born baby
CT scan Hydranencephaly, gross dilatation of lateral and third ventricle,
minimal visible brain parenchyma, extensive gyral and basal
ganglia calcification
Treatment Anti-Toxoplasma therapy: spiramycin
In 2002: Clinical manifestation Quadriplegic cerebral palsy
Investigation
MRI Brain is small with dilated lateral ventricle
VEP studies Severe lesion at visual pathway level
Ophthalmoscopic examination Rt eye showed macular scar; Lt eye was normal
Serodiagnosis Both CSF and serum showed positive for IgG and IgM
anti-Toxoplasma antibodies
Treatment Replaced by ventral-peritoneal (VP) shunt
Anti-Toxoplasma therapy: fansidar
Follow-up Yes
Other complications Recurrent VP shunt infections, resolved MRSE meningitis,
urinary tract infection and pneumonia
SOUTHEAST ASIAN J TROP MED PUBLIC HEALTH
56 Vol 36  (suppl 4)  2005
Malaysian scenario. There is speculation as to whether a
vaccine against cryptosporidiosis is a reality or fantasy
(de Graaf et al, 1999) due to its own virulence and
resistance to therapy, whereas vaccination for giardiasis
(Olson et al, 2000) may become an ultimate tool in
eradicating this protozoan parasite. In Malaysia, drinking
water contamination with Giardia and Cryptosporidium
oocysts has become one of the top agendas in public
health.
We found that Plasmodium vivax was the most
common cause of malaria in this study. This finding is
consistent with those reported earlier in domestic and
other regions (Norhayati et al, 2001; Kitvatanachai et
al, 2003; Koh et al, 2004) but contrary to others (Sidhu
and Ng, 1991; Jamaiah et al, 1998). We observed that
the majority of these patients were foreign workers,
which indicates that imported malaria still exists and
there is an urgent need to prevent or control
transmission. Fever, chills and rigors were the
commonest clinical presentations, similar to another
study (Suyaphun et al, 2002). This suggests that
malaria should be included in the differential diagnoses
for any patient with pyrexia of unknown origin (PUO)
or a history of traveling in the tropics. The peripheral
blood smear is the conventional, reliable gold standard
to detect malaria parasites used in our study, even
though many novel modified techniques have been
discovered in recent years. The treatment of choice
for vivax malaria in this study was chloroquine and
subsequently primaquine, while one study suggested
that the combination of artesunate (5 days) and
primaquine (14 days) has proven to be a highly
effective and generally well-tolerated treatment
regimen (Silachamroon et al, 2003). No anti-malarial
drug resistance was noted in this study; however,
previous studies showed that vivax malaria parasites
have developed resistance to chloroquine and other
drugs (Longworth, 1995; Kshirsagar et al, 2000).
Nevertheless, one study showed that the epidemic
outbreak has not been due to the presence of
chloroquine resistant P. vivax (Congpuong et al, 2002).
Toxoplasmosis is a protozoan disease with a world-
wide distribution and most infections in humans are
asymptomatic. In our study, we found 10 cases of
toxoplasmic encephalitis (TE). TE is the most common
intracerebral lesion in AIDS patients and is due to
reactivation of latent Toxoplasma infection.
Interestingly, CT scan and serodiagnosis were the main
investigations in all TE cases. However, we also
support the existing PCR, which has consistently
proven to be useful in TE diagnosis as verified in
previous studies (Dupouy-Camet et al, 1993; Joseph
et al, 2002; Vidal et al, 2004). The frequency of TE in
AIDS patients varies from about one fourth to one half
of cases in the absence of antimicrobial prophylaxis
(Cohen, 1999). In the era of HAART, prophylaxis
against TE is cost-effective (Yazdanpanah et al, 2003),
and lessens the burden of hospitalization (Khetsuriani
et al, 2002). Therefore, recommendations on
prophylaxis and maintenance therapy need to be
redefined (Furrer et al, 2002). HAART has improved
the outcome of patients with AIDS who have CNS
infections, and the initiation of this therapy is
mandatory if effective therapy is not available
(Collazos, 2003); moreover, there is no increase in the
risk of developing TE after beginning HAART if the
TE patient discontinues anti-Toxoplasma prophylaxis
(Pozio, 2004). We found one confirmed case of TE
relapse, the cause of which may have been due to side
effects or non-compliance to anti-Toxoplasma therapy.
In this context, atovaquone containing regimens are
well tolerated, safe, and may be useful for patients
intolerant of standard regimens for TE (Chirgwin et
al, 2002). Nonetheless, the development of novel anti-
Toxoplasma drugs may prove to be more effective
against Toxoplasma infection, particularly its cyst form.
Ocular toxoplasmosis (OT) was the most common
clinical manifestation of Toxoplasma infection in this
study. The majority of OT patients were in the 2nd and
3rd decades of life. Ocular toxoplasmosis is either due
to congenital or acquired infection, and it is possible
to show that many cases are congenital and others are
acquired (Ho-Yen, 1992). The typical clinical
presentations found in these patients correlated with
previous studies (Zurainee et al, 2000; Suhardjo et al,
2003). This indicates that toxoplasmosis should be
included in the differential diagnoses for any highly
suspected ocular cases. It showed that serodiagnosis
for anti-Toxoplasma antibodies was the confirmatory
investigation. Congenital ocular toxoplasmosis does
not always show an increase in anti-Toxoplasma (IgM)
antibody, especially in the case of chorioretinal scarring
– a finding which most cases with positive IgG also
encountered in our study; furthermore, anti-
Toxoplasma titer positivity has been an important factor
in determining whether the lesion found was active or
not (Suhardjo et al, 2003). Clindamycin was the most
common antibiotic used, either single or combined
therapy – a promising agent in the management of
ocular toxoplasmosis.  Most cases of OT were recurrent
in this study. The risk of recurrent ocular disease
appeared to be greatest during the first year after an
initial episode of toxoplasmic retinochoroiditis
(Holland, 2003). A few studies showed that long-term
intermittent trimethoprim/sulfamethoxazole or
chemoprophylaxis reduced the rate of recurrent
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toxoplasmic retinochoroiditis in immunocompetent
cases and high-risk patients (Silveira et al, 2002; Kopec
et al, 2003; Holland, 2004). This indicates that OT
cases are still common in clinical practice.
Only one case of congenital toxoplasmosis was
encountered in this study. The incidence of congenital
toxoplasmosis has been more widely reported in
Europe (Munoz Batet et al, 2004), whereas the true
incidence of congenital toxoplasmosis in Malaysia is
unknown. Serological surveys conducted in pregnant
women have shown that toxoplasmosis is a common
infection in this country as reported in earlier studies
(23% to 49%) (Cheah et al, 1975; Nissapatorn et al,
2003). Therefore, it is most likely that toxoplasmosis
is an important cause of congenital infection in
Malaysia. Our data also showed that this pediatric
patient had obvious brain and eye involvement at first
detection during antenatal examination. This finding
is consistent with one previous study (Mets et al, 1996)
but not consistent with another from Malaysia (Tan
and Mak, 1985). This suggests the importance of
imaging in diagnosing congenital toxoplasmosis.
Serodiagnosis – particularly IgM for Toxoplasma
infection – plays a very important role to confirm the
diagnosis, as shown in one previous study (Lebech et
al, 1999).  We strongly recommend the possibility of
early prenatal diagnosis of congenital Toxoplasma
infection using an approach based on PCR (Grover et
al, 1990; Hohlfeld et al, 1994) performed on amniotic
fluid – which is rapid, sensitive, safe, and accurate. In
addition, the pyrimethamine-sulfa drug combination
given to mothers of proven infected fetuses, and
extended to well-documented seroconverted mothers
can be effective (Couvreur et al, 1991).
In conclusion, these common parasitic infections
are still viable and prevalent in Malaysia. We therefore
suggest the following agenda: firstly more
epidemiological studies need to be carried out in larger
scales and in different target populations; secondly, the
appropriate routine diagnosis, particularly novel
laboratory techniques, should be well equipped, easy,
cheap, and not time consuming – especially when
screening a mass community; lastly, standard strategies
including health education should be consistently
implemented throughout the country. We would then
expect that the incidence of parasitic infections would
be markedly reduced or eradicated from this region in
the future.
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